|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||48.05 / 65.50|
The company is on track for another terrific year of double digit earnings per share growth.
The Abbott Park, Ill., healthcare company beats top- and bottom-line estimates and raises its full-year outlook for earnings.
This group is expected to post second-quarter EPS gains of 30%; here is how to trade it.
- Second-quarter reported sales growth of 17.0 percent; GAAP EPS from continuing operations of $0.40
U.S. stock futures are flat on Wednesday, following an upbeat assessment of the U.S. economy from Federal Reserve Chairman Jerome Powell; Morgan Stanley and IBM report earnings; Google faces a record $5 billion fine from the European Union.
In April, CEO Miles White said the healthcare company had paid down $6 billion of debt this year and expected to pay down another $2 billion by the end of 2018.
U.S. stocks ended the week higher as earnings season got underway and investors shook off the latest round of trade tensions
- Innovations designed to allow doctors to treat more types of cases and anatomies - MitraClip is the gold-standard minimally invasive alternative to open-heart surgery for people needing mitral valve repair - Mitral regurgitation, the most common heart...
- Two-Thirds of Millennials Aren't Saving for Retirement
- Expanded Real-World Evidence from More than 250,000 individuals using Freestyle libre system Showed Higher Frequency Scanning is Associated with improved glucose control, decreased glucose variability and reduced incidence of both daytime and nocturnal hypoglycemia
Markets had a tumultuous week starting with increased trade war fears and ending with a modest oil production increase from OPEC.
ABBOTT PARK, Ill., June 20, 2018 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its second-quarter 2018 financial results on Wednesday, July 18, 2018, before the market opens.
Jim Cramer says higher rates always trigger rotations. Here's what investors should expect.
ABBOTT PARK, Ill., June 8, 2018 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 28 cents per share.
Looking for good stock ideas? TheStreet has you covered with a plethora of names gleaned from our readings.
STATE-OF-THE-ART MULTI-ASSAY TEST SYSTEM HELPS PEOPLE WITH DIABETES GET THE HbA1c RESULTS THEY NEED WITHIN 3 MINUTES -- ALLOWING MORE TIME FOR CONSULTATION AND CARE DURING A SINGLE HEALTHCARE VISIT
The Memorial Day holiday is now over, and it's time for investors to get back to work looking for top stocks. TheStreet's founder Jim Cramer has a must watch list.
When chartists look for the next market leaders they often go to stocks that have held up the best during corrections.
When rates decline, most of the S&P 500 benefits, according to TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer.
The crash of oil will only accelerate the move.
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Abbott Laboratories has taken over the #38 spot from NextEra Energy Inc , according to ETF Channel. Below is a chart of Abbott Laboratories versus NextEra Energy Inc plotting their respective rank within the S&P 500 over time (ABT plotted in blue; NEE plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.
- XIENCE Sierra™, the newest generation of XIENCE drug-eluting stents, received U.S. Food and Drug Administration (FDA) approval
- Promising results for Tendyne valve presented as late-breaking clinical trial at EuroPCR
Conference highlights from Honeywell bolster the investment case.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.